Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice.

Neurobiology of disease - 1 Oct 2014

Nicks Jessica, Lee Sooyeon, Harris Andrew, Falk Darin J, Todd Adrian G, Arredondo Karla, Dunn William A, Notterpek Lucia

Abstract excerpt

Charcot--Marie-Tooth disease type 1A (CMT1A) is a hereditary peripheral neuropathy characterized by progressive demyelination and distal muscle weakness. Abnormal expression of peripheral myelin protein 22 (PMP22) has been linked to CMT1A and is modeled by Trembler J (TrJ) mice, which carry the s...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Injections, Intraperitoneal
Share to Myelin Sheath
Share to Neuroprotective Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Peripheral Nervous System Diseases

Share to Rotarod Performance Test

Share to Schwann Cells

Share to Sirolimus

Share to Tissue Culture Techniques

Source

Open in PubMed Open full text

Identifiers

PMID: 25014022
DOI: 10.1016/j.nbd.2014.06.023
PMCID: PMC4532623

Genes

PMP22

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-25014022-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rapamycin improves peripheral nerve myelination while it fails to benefit neuromuscular performance in neuropathic mice.PMID 25014022Read ↗

Inversely proportional myelin growth due to altered <i>Pmp22</i> gene dosage identifies PI3K/Akt/mTOR signaling as a novel therapeutic target in HNPPSemantic proximity Read ↗

Schwann cell autophagy counteracts the onset and chronification of neuropathic painSemantic proximity Read ↗

Early targeting of endoneurial macrophages alleviates the neuropathy and affects abnormal Schwann cell differentiation in a mouse model of Charcot‐Marie‐Tooth 1ASemantic proximity Read ↗

Curcumin and Ethanol Effects in Trembler-J Schwann Cell CultureSemantic proximity Read ↗

Treatment with IFB-088 improves neuropathy in CMT1A and CMT1B miceSemantic proximity Read ↗

Chronic Rapamycin administration via drinking water mitigates the pathological phenotype in a Krabbe disease mouse model through autophagy activation.Semantic proximity Read ↗

Polytherapy with a combination of three repurposed drugs (PXT3003) down-regulates Pmp22 over-expression and improves myelination, axonal and functional parameters in models of CMT1A neuropathySemantic proximity Read ↗

Myelin and axon pathology in a long-term study of PMP22-overexpressing mice.Semantic proximity Read ↗

Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A PatientsSemantic proximity Read ↗

The role of TSC1 and TSC2 proteins in neuronal axons.Semantic proximity Read ↗

Distinct and additive effects of calorie restriction and rapamycin in aging skeletal muscleSemantic proximity Read ↗

Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.